RT Journal Article
SR Electronic
T1 Scleroderma: A treatable disease
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 954
OP 968
VO 70
IS 11
A1 Korn, Joseph H.
YR 2003
UL http://www.ccjm.org/content/70/11/954.abstract
AB Many effective treatments for scleroderma have emerged in recent years, including bosentan, an endothelin receptor antagonist, and epoprostenol, a prostacyclin, both of which target vasoconstriction. Cyclophosphamide may soon be proven effective against interstitial lung disease.